Prof. Dr.Ergün Tozkoparan

  • İlgi Alanları
  • Girişimsel pulmonoloji
  • Sarkodioz
  • İnterstisyel akciğer hastalıkları
  • Akciğer enfeksiyonları
  • Astım
  • Koah
  • Plevra hastalıkları
  • Palyatif bakım

Eğitim ve Uzmanlık
1989 - GATA Askeri Tıp Fakültesi -Tıp eğitimi)
1996 - GATA, Ankara- uzmanlık eğitimi

Deneyim
1996 - 1999: Göğüs Hastalıkları Uzmanı, GATA Çamlıca Göğüs Hastalıkları Hastanesi, İstanbul
1999 - 2002: Göğüs Hastalıkları Uzmanı, Mareşal Çakmak Asker Hastanesi, Erzurum
2002 - 2006: Yardımcı Doçent, GATA Göğüs Hastalıkları Anabilim Dalı
2006 - 2013: Doçent , GATA Göğüs Hastalıkları Anabilim Dalı
2006: Yurt Dışı Eğitim: Texas Üniversitesi, MD Anderson Kanser Merkezi, Göğüs Hastalıkları Bölümü, Girişimsel Pulmonoloji Birimi, Houston, Texas, ABD (12 ay)
2013 - 20106: Profesör, GATA Göğüs Hastalıkları Anabilim Dalı
2014 - 2016: Anabilim Dalı başkanı: GATA Göğüs Hastalıkları Anabilim Dalı

Mesleki Üyelikler
Türkiye Solunum Araştırmaları Derneği
(Girişimsel Pulmonoloji Çalışma Grubu Başkanı; 2015-2016)
Türk Toraks Derneği
European Respiratory Society

Ödüller
2009 Asya-Pasifik Solunum Kongresi: En iyi araştırma ödülü

1)        The impact of sedation type on diagnostic yield of EBUS-TBNA: Looking from another point of view. Gümüş S, Kaya H, Turhan U, Özkısa T,Tozkoparan E. Clin Respir J. 2016 Jul 16. doi: 10.1111/crj.12532. [Epub ahead of print].

2)        Effects of radiological extent on neutrophil/lymphocyte ratio in pulmonary sarcoidosis. Ocal N, Dogan D, Ocal R,Tozkoparan E, Deniz O, Ucar E, Gumus S, Tasci C, Yildiz B, Taskin G, Taskin A, Badem S, Turhan U. Eur Rev Med Pharmacol Sci. 2016;20(4):709-14.

3)        Paradoxical relationship between TNF-alpha antagonists and sarcoidosis. Baygin N, Tozkoparan E. Semin Arthritis Rheum. 2014 Apr;43(5):e2. doi: 10.1016/j.semarthrit.2013.11.001. Epub 2013 Nov 13..

4)        Response.Kaya H, Gümüş S, Uçar E, Aydoğan M, Muşabak U,Tozkoparan E, Bilgiç H.Chest. 2013 Jan;143(1):274-5. doi: 10.1378/chest.12-2249..

5)        The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis.Tascı C, Ozkaya S, Ozkara B,Tozkoparan E, Ozkan M, Karadurmus N, Serdar M, Balkan A, Bilgic H.Onco Targets Ther. 2012;5:385-90. doi: 10.2147/OTT.S32888. Epub 2012 Nov 22.

6)        Omalizumab as a steroid-sparing agent in chronic eosinophilic pneumonia.Kaya H, Gümüş S, Uçar E, Aydoğan M, Muşabak U,Tozkoparan E, Bilgiç H.Chest. 2012 Aug;142(2):513-6. doi: 10.1378/chest.11-1881.

7)        Serum chitotriosidase activity in pulmonary tuberculosis: response to treatment and correlations with clinical parameters.Cakır G, Gumus S, Ucar E, Kaya H,Tozkoparan E, Akgul EO, Karaman B, Deniz O, Kurt I, Ozkan M, Bilgic H.Ann Lab Med. 2012 May;32(3):184-9. doi: 10.3343/alm.2012.32.3.184. Epub 2012 Apr 18.

8)        Pulmonary Rehabilitation Using Modified Threshold Inspiratory Muscle Trainer (IMT) in Patients with Tetraplegia.Yasar F, Tasci C, Savci S,Tozkoparan E, Deniz O, Balkan A, Bilgic H. Case Rep Med. 2012;2012:587901. doi: 10.1155/2012/587901. Epub 2012 Mar 26.

9)        Serum lactate dehydrogenase levels significantly correlate with radiological extent of disease and spirometric values in patients with silicosis due to denim sandblasting.Deniz O, Gumus S, Ors F, Yaman H, Battal B, Karaman B, Acikel CH, Ucar E, Cakir E,Tozkoparan E, Bilgic H. Clin Chem Lab Med. 2012 Jan 31;50(3):483-8. doi: 10.1515/cclm.2011.795.

10)      Serum prolidase activity in patients with pulmonary tuberculosis. Gumus S, Yaman H, Ozcan O, Deniz O, Karaman B, Cakir E,Tozkoparan E, Ozkan M, Bilgic H. Scand J Clin Lab Invest. 2011 Oct;71(6):467-72. doi: 10.3109/00365513.2011.587021. Epub 2011 Jul 4.

11)      The role of oxidative stress and effect of alpha-lipoic acid in reexpansion pulmonary edema - an experimental study.Gumus S, Yucel O, Gamsizkan M, Eken A, Deniz O,Tozkoparan E, Genc O, Bilgic H.Arch Med Sci. 2010 Dec;6(6):848-53. doi: 10.5114/aoms.2010.19290. Epub 2010 Dec 29.

12)      Effect of nail polish and henna on oxygen saturation determined by pulse oximetry in healthy young adult females.Sütçü Çiçek H, Gümüs S, Deniz Ö, Yildiz S, Açikel CH, Çakir E,Tozkoparan E, Uçar E, Bilgiç H.Emerg Med J. 2011 Sep;28(9):783-5. doi: 10.1136/emj.2010.096073. Epub 2010 Oct 5.

13)      Proanthocyanidin to prevent formation of the reexpansion pulmonary edema.Yucel O, Ucar E,Tozkoparan E, Gunal A, Akay C, Sahin MA, Genc O.J Cardiothorac Surg. 2009 Jul 28;4:40. doi: 10.1186/1749-8090-4-40.

14)      Invasive pulmonary aspergillosis after liver transplantation: rapid and complete response to combined and sequential antifungal therapy.Can MF, Yagci G, Gorenek L,Tozkoparan E, Ozerhan I, Cetiner S.Surg Infect (Larchmt). 2008 Feb;9(1):99-104. doi: 10.1089/sur.2006.094. Review.

15)      Changes in platelet count and indices in pulmonary tuberculosis.Tozkoparan E, Deniz O, Ucar E, Bilgic H, Ekiz K.Clin Chem Lab Med. 2007;45(8):1009-13.

16)      High-resolution CT findings in patients with pulmonary tuberculosis: correlation with the degree of smear positivity.Ors F, Deniz O, Bozlar U, Gumus S, Tasar M,Tozkoparan E, Tayfun C, Bilgic H, Grant BJ.J Thorac Imaging. 2007 May;22(2):154-9.

17)      Idiopathic pulmonary hemosiderosis in an adult patient responded well to corticosteroid therapy. Deniz O, Ongürü O, Ors F, Gümüş S,Tozkoparan E, Bilgiç H, Ekiz K.Tuberk Toraks. 2007;55(1):77-82.

18)      Genetic diversity of Mycobacterium tuberculosis isolates at the Military Medical Academy in Ankara, Turkey.Kisa O, Albay A, Baylan O,Tozkoparan E, Acikel CH, Doganci L. Res

19)      Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis.Deniz O, Gumus S, Yaman H, Ciftci F, Ors F, Cakir E,Tozkoparan E, Bilgic H, Ekiz K.Clin Biochem. 2007 Feb;40(3-4):162-6. Epub 2006 Nov 21.

20)      Primary nasolacrymal tuberculosis diagnosed after dacryocytorhinostomy.Tosun F,Tozkoparan E, Erdurman C, Ors F, Deniz O. Auris Nasus Larynx. 2007 Jun;34(2):233-5. Epub 2006 Sep 29.

21)      Diagnostic value of leptin in tuberculous pleural effusions.Celik G, Kaya A, Poyraz B, Ciledag A, Elhan AH, Oktem A,Tozkoparan E, Ozkan M.Int J Clin Pract. 2006 Nov;60(11):1437-42. Epub

22)      Reduced pulmonary function in wind instrument players.Deniz O, Savci S,Tozkoparan E, Ince DI, Ucar M, Ciftci F.Arch Med Res. 2006 May;37(4):506-10.

23)      Serum HDL-C levels, log (TG/HDL-C) values and serum total cholesterol/HDL-C ratios significantly correlate with radiological extent of disease in patients with community-acquired pneumonia.Deniz O,Tozkoparan E, Yaman H, Cakir E, Gumus S, Ozcan O, Bozlar U, Bilgi C, Bilgic H, Ekiz K. Clin Biochem. 2006 Mar;39(3):287-92. Epub 2006 Feb 20.

24)      Atopy in patients with bronchiectasis: more than coincidence. Ozturk S,Tozkoparan E, Karaayvaz M, Caliskaner Z, Gulec M, Deniz O, Ucar E, Ors F, Bozlar U. Tohoku J Exp Med. 2006 Jan;208(1):41-8.

25)      The significance of elevated brain natriuretic peptide levels in chronic obstructive pulmonary disease.Bozkanat E,Tozkoparan E, Baysan O, Deniz O, Ciftci F, Yokusoglu M. J Int Med Res. 2005 Sep-Oct;33(5):537-44.

26)      The diagnostic values of serum, pleural fluid and urine neopterin measurements in tuberculous pleurisy. Tozkoparan E, Deniz O, Cakir E, Yaman H, Ciftci F, Gumus S, Ozcan O, Akgul OE, Bilgic H, Erbil K, Ekiz K. Int J Tuberc Lung Dis. 2005 Sep;9(9):1040-5.

27)      High resolution computed tomographic features of pulmonary alveolar microlithiasis. Deniz O, Ors F,Tozkoparan E, Ozcan A, Gumus S, Bozlar U, Bilgic H, Ekiz K, Demirci N. Eur J Radiol. 2005 Sep;55(3):452-60.

28)      The roles of HRCT and clinical parameters in assessing activity of suspected smear negative pulmonary tuberculosis. Tozkoparan E, Deniz O, Ciftci F, Bozkanat E, Bicak M, Mutlu H, Ors F, Bilgic H, Demirci N. Arch Med Res. 2005 Mar-Apr;36(2):166-70.

29)      Delay in the diagnosis of Turkish servicemen with pulmonary tuberculosis. Okutan O, Kartaloglu Z, Cerrahoglu K, Ilvan A,Tozkoparan E, Aydilek R. Mil Med. 2005 Mar;170(3):211-3.

30)      Low parathormone levels and hypercalcaemia in patients with pulmonary tuberculosis: relation to radiological extent of disease and tuberculin skin test. Deniz O,Tozkoparan E, Yonem A, Ciftci F, Bozkanat E, Cakir E, Ozcan O, Narin Y, Bilgic H, Ekiz K, Demirci N. Int J Tuberc Lung Dis. 2005 Mar;9(3):317-21.

31)      Pleural fluid and serum procalcitonin as diagnostic tools in tuberculous pleurisy. Cakir E, Deniz O, Ozcan O,Tozkoparan E, Yaman H, Akgul EO, Bilgi C, Bilgic H, Ekiz K, Erbil MK. Clin Biochem. 2005 Mar;38(3):234-8.

32)      The incidence of tuberculosis in the armed forces: a good reflection of the whole population. Ciftci F,Tozkoparan E, Deniz O, Bozkanat E, Kibaroglu E, Demirci N. Int J Tuberc Lung Dis. 2004 Aug;8(8):965-8.

33)      Urinary neopterin measurement as a non-invasive diagnostic method in pulmonary tuberculosis. Yuksekol I, Ozkan M, Akgul O,Tozkoparan E, Al-Rashed M, Balkan A, Hatipoglu K, Bilgic H, Erbil K, Demirci N. Int J Tuberc Lung Dis. 2003 Aug;7(8):771-6.

34)      Unusual miliary tuberculosis presenting with generalized lymphadenopathy and abdominal involvement. Köylü R,Tozkoparan E, Pabuşçu Y, Ciftçi F, Bilgiç H, Seber O. Int J Tuberc Lung Dis. 1997 Oct;1(5):474-6